drugset / Trial / NCT03266237
The Immune Response to Influenza Vaccinations in Elderly Individuals
Phase 4
Completed
240 enrolled
National University Hospital, Singapore
Agency for Science, Technology and Research · collabNational University of Singapore · collabSanofi Pasteur, a Sanofi Company · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
The aim of this study is to characterize the immune profile of frail and healthy aged individuals and investigate their immune responsiveness including the response to influenza vaccine over an 18-month period. The project will include a longitudinal study to define immune signatures and multi-parameter profiles associated with frailty and may lead to the identification of predictive markers of evolution to frailty and Immunosenescence in the elderly.
Timeline
- Start
- 2013-12
- Primary completion
- 2016-05
- Completion
- 2016-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Influenza Virus Vaccine | Vaccine | — | Intramuscular |